CME Group Inc. (CME) Drops 1.17% After Earnings, EPS Exceeds Estimates, Sales Above Forecast

2026-02-04 · Stocks · QuoteReporter

Post Earning Analysis

CME Group Inc. (CME) Drops 1.17% After Earnings, EPS Exceeds Estimates, Sales Above Forecast

CME Group, Inc., founded in 1898 and headquartered in Chicago, operates a leading derivatives marketplace. The company provides a diverse range of futures and options products for risk management, with offerings in major asset classes such as interest rates, equity indexes, FX, energy, agricultural commodities, and metals. It facilitates trading via platforms like CME Globex, BrokerTec, and EBS, and operates CME Clearing, a central counterparty clearing provider.

CME Group Inc. has reported a strong performance in the fourth quarter of 2025, surpassing both earnings and revenue estimates. The company declared its fourth consecutive year of record annual revenue, adjusted operating income, adjusted net income, and adjusted earnings per share. This financial achievement is highlighted by the company’s January trading volume, which set a new record of 29.6 million contracts, marking a 15% increase year over year. These positive results could potentially lead to increased investor confidence and a positive impact on CME Group’s stock price.

Additionally, the overall sentiment in the agricultural sector has seen a sharp decline at the start of 2026 due to rising economic concerns, which could influence market dynamics related to commodities trading, an area where CME Group is significantly involved. This change in sentiment may affect trading volumes or the volatility of commodity prices, potentially impacting CME’s future performance.

The current price of $289.58 represents a slight decline of 1.17% today, positioning it near the upper range of its recent performance metrics. The price is just 2.22% below the 52-week and year-to-date high of $296.16, indicating a strong upward trend over the past year. This is further supported by its significant recovery from the year-to-date low of $220.42, marking a substantial 31.38% increase.

The stock has been consistently performing well above its moving averages, with current prices 3.67%, 5.06%, and 6.64% above the 20-day, 50-day, and 200-day moving averages, respectively. This suggests a strong bullish trend in the medium to long term.

The Relative Strength Index (RSI) of 63.97 indicates that the stock is neither overbought nor oversold, supporting a stable outlook. The positive MACD value of 4.96 further confirms the bullish momentum, as it reflects a sustained upward movement in price.

Overall, the stock’s performance is robust, with its proximity to its 52-week high and positive indicators from the RSI and MACD suggesting the potential for continued upward movement, albeit with usual market fluctuations.

CME Group Inc. (NASDAQ: CME) reported robust financial results for the fourth quarter and full-year 2025 on February 4, 2026. For Q4, the company achieved a total revenue of $1.6 billion, marking an 8% increase from the $1.5253 billion reported in Q4 2024. Operating income also rose by 8% to $1.0 billion, while net income surged by 35% to $1.2 billion, compared to $874.6 million in the same quarter of the previous year. The diluted earnings per share (EPS) increased significantly by 35% to $3.24.

For the full year, CME Group’s total revenue was $6.5 billion, up 6% from $6.13 billion in 2024. The operating income for the year stood at $4.2 billion, an 8% increase, and net income rose by 16% to $4.1 billion. The full-year diluted EPS was $11.16, reflecting a 15% growth.

The company also highlighted a 7% increase in average daily volume for Q4, reaching 27.4 million contracts. Additionally, market data revenue grew by 14% to $208 million. CME Group’s strategic focus includes expanding services such as U.S. Treasury clearing, 24/7 cryptocurrency trading, and prediction markets initiatives. With a strong cash position of approximately $4.6 billion and total dividends paid in 2025 nearing $3.9 billion, CME Group continues to demonstrate its commitment to shareholder returns and strategic growth.

Earnings Trend Table

Analyzing the EPS trends from the data provided, a clear pattern of consistent outperformance relative to estimates is evident across multiple quarters. Starting from the quarter ending in October 2023, the Reported EPS has consistently surpassed the Estimate EPS, albeit with varying degrees of surprise percentage. The surprise percentage, which measures the extent to which the actual EPS exceeds the analyst estimates, shows fluctuations but remains positive in each instance, indicating better-than-expected financial results.

The Reported EPS shows a gradual upward trend from 2.25 in October 2023 to 2.77 by February 2026. This incremental increase suggests a steady improvement in the company’s profitability over the period. The estimates also reflect a similar upward trajectory, although they slightly underestimate the actual figures in most quarters. The highest surprise came in February 2024, with a 3.84% positive deviation from the estimates, highlighting a particularly strong quarter relative to expectations.

Overall, the data reflects robust financial performance with consistent overachievement relative to analysts’ forecasts, which could be indicative of strong operational management and possibly a conservative estimation approach by analysts.

Dividend Payments Table

The dividend data presented indicates a notable trend and a significant adjustment in the dividend payouts over the specified period. Throughout 2025, the dividends remained constant at $1.25 each quarter, suggesting a stable payout policy during this year. This consistency might reflect the company’s solid financial health and a commitment to maintaining shareholder returns.

In contrast, the year 2024 shows variability and a particularly unusual spike. For the majority of 2024, dividends were steady at $1.15 per quarter, demonstrating a regular disbursement similar to the following year’s pattern. However, there is a striking increase to $5.8 in December 2024. This substantial rise could be indicative of a special dividend or possibly an adjustment reflecting a one-time financial strategy, such as distributing accumulated profits.

Overall, the increase in the regular dividend amount from $1.15 in 2024 to $1.25 in 2025 suggests a positive adjustment in the company’s dividend policy, potentially pointing to improved profitability or a strategic decision to increase shareholder value consistently.

The most recent rating changes for the stock in question present a notable trend, with three upgrades and one downgrade occurring within a six-month period.

1. TD Cowen on January 14, 2026: The most recent rating change came from TD Cowen, which upgraded the stock from ‘Hold’ to ‘Buy’ with a target price set at $305. This upgrade likely reflects TD Cowen’s increased confidence in the company’s operational performance and future growth prospects, suggesting a potential undervaluation at previous levels.

2. Deutsche Bank on October 23, 2025: Shortly before TD Cowen’s upgrade, Deutsche Bank also adjusted its stance on the stock, upgrading from ‘Hold’ to ‘Buy’ with a target price of $300. This indicates a positive reassessment of the company’s market position and expected financial results, aligning with a bullish outlook on its value.

3. Citigroup on September 25, 2025: Citigroup upgraded the stock from ‘Neutral’ to ‘Buy’, setting the target price at $300. This upgrade could be attributed to improved company fundamentals or sector dynamics that Citigroup believes will drive the stock’s performance upwards.

4. UBS on July 24, 2025: Contrasting with the subsequent upgrades, UBS downgraded the stock from ‘Buy’ to ‘Neutral’, albeit with a relatively high target price of $305. This downgrade might suggest a perceived plateau in the stock’s growth trajectory or potential risks that could cap further appreciation, despite a still optimistic price target.

Overall, the predominance of upgrades suggests a generally positive outlook among analysts regarding the company’s future, with a consensus forming around a target price in the $300-$305 range. However, UBS’s earlier downgrade provides a cautious note, indicating possible concerns or a more conservative view of the stock’s growth potential.

The current price of the stock stands at $289.58. This figure is notably below the average target price provided by various analysts, which hovers around $302.50. This average target price is derived from recent ratings by TD Cowen, Deutsche Bank, and Citigroup, each suggesting a move to a “Buy” status with target prices of $305 and $300 respectively. UBS, however, adjusted their rating to “Neutral” from “Buy” but maintained a target price of $305.

This discrepancy between the current price and the target prices indicates a potential undervaluation, suggesting room for growth according to the analysts’ forecasts. The recent upgrades from major financial institutions like TD Cowen, Deutsche Bank, and Citigroup also reflect a positive outlook on the stock, potentially driven by underlying improvements in the company’s financial health or market position. The consistent target price of $305 by TD Cowen and UBS, despite the latter’s downgrade, further underscores a consensus on the stock’s value potential.

Disclaimer: The information provided here is for educational and informational purposes only and should not be interpreted as financial advice, investment recommendations, or trading guidance. Markets involve risk, and past performance is not indicative of future results. You should always conduct your own research and consult with a qualified financial advisor before making any investment decisions. By acting, you accept full responsibility for your choices.